Stay updated with breaking news from Nasdaq Dcph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) traded down 6.3% on Wednesday . The stock traded as low as $14.44 and last traded at $14.51. 150,124 shares were traded during mid-day trading, a decline of 77% from the average session volume of 645,505 shares. The stock had previously closed at $15.48. Wall […]
Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report) released its earnings results on Wednesday. The company reported ($0.57) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.62) by $0.05, Briefing.com reports. Deciphera Pharmaceuticals had a negative net margin of 129.90% and a negative return on equity of 47.99%. The company had revenue […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report)’s stock price was down 3.9% on Monday . The stock traded as low as $13.16 and last traded at $13.18. 40,322 shares traded hands during trading, a decline of 94% from the average daily volume of 669,164 shares. The stock had previously closed at $13.71. Analysts Set […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 3,790,000 shares, a drop of 14.1% from the June 15th total of 4,410,000 shares. Based on an average daily trading volume, of 533,300 […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 4,310,000 shares, an increase of 14.9% from the May 15th total of 3,750,000 shares. Based on an average daily volume of 622,700 shares, the […]